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Introduction
The coexistence of  pregnancy and malignancy is a rare 
phenomenon with an incidence rate of  1 in 1000 pregnancies 
in the developed world1–4. The incidence in Africa is thought 
to be lower than that of  developed countries because women 
in developing countries get pregnant at younger ages5. Among 
the malignancies that have been recorded to co-exist with 
pregnancy, 70-80% of  the cases were the following cancers: 
breast, cervical, lymphoma, ovarian, and melanoma2,6. 
Queen Elizabeth Central Hospital (QECH) records indicate 
that 11 (1.05%) of  female cancer patients who presented 
between 1 January 2015 and 31 December 2017 were 
pregnant. Among these patients, haematological malignancies 
were the most common (n=6) followed by breast carcinoma 
(2), Kaposi’s sarcoma (1), Osteosarcoma (1) and Wilms’ 
tumour (1).
Wilms’ tumour has an incidence of  10 cases/million children 
with a median age of  3.5 years at the time of  diagnosis7,8. It 
accounts for 6% of  paediatric malignancies and is associated 
with a 42% five-year event free survival at QECH9,10. Adult 
Wilms’ Tumour (AWT) has an estimated incidence of  <0.2 
cases/million individuals in western countries(0.5% of  all 
adult renal neoplasms)11–13. Its incidence is associated with 
mutations in WT1, CTNNB1, IGF2 and WTX genes14. 
Adult Wilm’s tumour has a worse prognosis due to lack of  
established treatment protocols, its highly aggressive course 
and metastatic potential7,13. Adults also tend to have a lower 
drug toxicity threshold and advanced disease at the time of  
diagnosis7,13,15.
Adult Wilm’s tumour diagnosis is based on the criteria 
developed by Kilton et. al which are: a primary renal 
neoplasm in the age group of  >15 years with histological 
features of  embryonic glomerulo-tubular structure with 
immature spindle or round cell stroma and no areas of  
tumour diagnostic of  renal cell carcinoma11,13.
Case Presentation
In January 2016, a 23 year old HIV negative woman 
presented at the QECH oncology clinic with a diagnosis of  
International Society of  Paediatric Oncology stage IV High 
risk AWT made at Nottingham University Hospital (August 
2014). At the time of  diagnosis, she had a primary tumour in 
the left kidney, a solitary liver metastasis and multiple right 
lung metastases. During her treatment course in Nottingham, 
she had actinomycin, vincristine and doxorubicin induction 
chemotherapy (August-October 2014) with partial response. 
This was changed to high-risk protocol: cyclophosphamide/
doxorubicin alternating with etoposide/carboplatin 
(November 2014).
In January 2015, she had a resection of  the primary tumour 
and liver metastasis. Radiotherapy to the left flank to a dose 
of  24 Grays and the whole right lung to a dose of  18 Grays 
followed (February 2015) and Doxorubicin was omitted 
during her radiotherapy. In September 2015 upon completion 
of  chemotherapy, CT scan confirmed partial response of  
her lung metastases and no evidence of  disease below the 
diaphragm. Resection of  the lung lesions was not feasible 
due to their multiplicity. Therefore close monitoring was 
opted for. No other significant medical history was available.
At the time of  presentation at QECH, socio-economic 
circumstances had limited her oncology care options to 
QECH. She also had no radiological evidence of  disease 
progression, an Eastern Cooperative Oncology Group 
performance status (ECOG) score of  1 (ambulatory but 
incapable of  strenuous work) and normal laboratory results. 
After 15 months on follow-up, she developed intermittent 
dyspnoea and right-sided chest pain. Chest radiograph 
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revealed right lung fibrotic changes in the upper lobe with 
collapse of  the middle and lower lung zone (Figure 2). 
A coincidental discovery of  pregnancy (G2P1) with an 
intrauterine singleton pregnancy of  15 weeks gestation 
age by ultrasound scan was also made. After non-directive 
counselling she opted for close follow-up.
A foetal anomaly scan at 22 weeks gestation revealed no 
anomalies and subsequent growth scans were normal. 
She developed lower back pain and had elevated serum 
calcium (3.2mmol/L, normal range: 2.0-2.5 mmol/L), 
Alkaline phosphatase (128.2U/L; 0-126 U/L) and lactate 
dehydrogenase (754.3 U/L; 0-248 U/L). MRI showed: 
a large left pleural effusion with multiple heterogeneous 
masses within the left lung, large mediastinal lymph nodes, 
and a large heterogeneous right kidney mass (Figures 3 & 4). 
he was started on Zoledronate 4mg IV and had a miscarriage 
two days later at 25 weeks gestation. She presented again 10 
days later and was started on chemotherapy while having an 
ECOG score of  3 (bedbound for >50% of  waking hours), 
cachexia and pitting oedema. Throughout the follow-up 
period she maintained normal renal function and had no 
thromboembolic events. She died of  lung failure two days 
after starting ifosfamide, carboplatin and etoposide.
Figure 4: Sagittal T2 weighted MRI sequence
Discussion
We accessed 10 reports on the coexistence of  AWT with 
pregnancy in published English literature16–26. It is our 
postulation that progressive tumours precipitated the 
miscarriage and this could have potentially been mitigated 
by early onset chemotherapy. Previous exposure to 
heavy treatment of  her metastatic disease and declining 
performance status however portended a poor prognosis27.   
Our patient also experienced the co-existence of  several 
factors associated with the development of  psychological 
distress namely: (I) young age, (II) advanced and recurrent 
disease, (III) declining functional status, (IV) previous 
experience with cancer therapy, (V) presence of  socio-
economic challenges and (VI) the maternal-foetal 
beneficence conflict resulting from cancer in pregnancy28–34. 
The presence of  psychological distress has been associated 
with disease progression or relapse, reduced quality-of-
life, impaired social relationships, increased risk of  suicide, 
longer rehabilitation time, poor adherence to treatment and 
shorter survival30,35–37. It is for this reason that distress and 
psychological support have been designated as a sixth vital 
sign and human right in cancer patients respectively38,39.
Management of  pregnancy-associated cancer is difficult due 
to lack of  robust evidence, paucity of  established treatment 
guidelines and complexity of  considerations including 
beneficence obligations of  clinicians to the mother and 
foetus28,40–43. Care for these patients in resource limited 
settings is also challenged due to availability of: (I)access 
to care, (II)diagnostic services, (III) treatment and (IV) 
personnel for interdisciplinary care10,39,44–47. Thus patients are 
likely to be diagnosed with advanced disease and experience 
delays in starting treatment; with consequential poor survival.
These challenges reflect resource distribution challenges 
which require long term investment in health care. The 
maternal-foetal ethical conflict highlights the importance 
of  patient education on fertility issues and provision of  
contraception.
Consent
Written informed consent was obtained from the patient 
for the publication of  this case report and accompanying 
images.
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